PVG.L Regulatory News (PVG)

12 May 2009 07:00



Ark Therapeutics Group plc

12 May 2009

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

1.  Name of the issuer

Ark Therapeutics Group PLC

2.  State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

(i)

3.  Name of person discharging managerial responsibilities/director

Andrew Christie

4.  State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

N/A

5.  Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

Beneficial holding of the person indicated in 3 above

6.  Description of shares (including class), debentures or derivatives or financial instruments relating to shares

1 pence ordinary shares

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

Andrew Christie

8  State the nature of the transaction

Purchase of shares

9. Number of shares, debentures or financial instruments relating to shares acquired

13,207 

10.  Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

0.006%

11.  Number of shares, debentures or financial instruments relating to shares disposed

N/A

12.  Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) 

N/A

13.  Price per share or value of transaction

52.5 pence

14.  Date and place of transaction

11 May 2009, UK

15.  Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

25,865  (0.012%)

16.  Date issuer informed of transaction

11 May 2009

17.  Any additional information

N/A

18.  Name of contact and telephone number for queries

Martyn Williams 020 7388 7722

Name of authorised official of issuer responsible for making notification

Martyn Williams

Company Secretary

Date of notification

12 May 2009